Monthly Archives: September 2018

SpinalCyte to Feature Fibroblast-Based Cell Therapy Results at the 2018 North American Spine Society Annual Meeting

HOUSTON, Sept. 24, 2018 /PRNewswire/ -- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of spinal discs using Human Dermal Fibroblasts, today announced it will be showcasing its fibroblast-based cell therapy product CybroCell at the North American Spine Society (NASS) 2018 Annual Meeting Sept. 26 - 29 in Los Angeles. The company recently published data in The Spine Journal that suggest

By |2018-09-24T16:47:54+00:00September 24th, 2018|Biologics|
Read More

TransEnterix Acquires Assets, Intellectual Property and Retains R&D Team from MST Medical Surgery Technologies

September 23, 2018 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has acquired substantially all of the assets of MST Medical Surgery Technologies Ltd. (“MST”), an Israel medical technology company, in a

By |2018-09-24T16:23:30+00:00September 24th, 2018|Financial|
Read More

MiMedx Provides Update on Previously Announced Senior Executive Separations

MARIETTA, Ga., Sept. 20, 2018 /PRNewswire/ -- The Board of Directors (the "Board") of MiMedx Group, Inc. (Nasdaq :MDXG ), a leading developer and marketer of regenerative and therapeutic biologics, today announced that it has determined that the previously announced separations of four senior MiMedx executives – Parker H. Petit, William C. Taylor, Michael J. Senken, and John E. Cranston (collectively, the "Separated Employees")

By |2018-09-24T15:22:46+00:00September 24th, 2018|Biologics|
Read More

CoreLink Surgical Announces the launch of Articulating Expandable Posterior Lumbar System – FLXfit®15

September 21, 2018 ST. LOUIS--(BUSINESS WIRE)--CoreLink Surgical today announces the expanded commercial launch for the FLXfit®15 articulating-expandable intervertebral body fusion device. FLXfit15 is a posterior lumbar expandable interbody device that offers up to 15 degrees of controlled and continuous expansion and is one of the only expandable cages on the market that offers articulation, providing

By |2018-09-24T15:03:38+00:00September 24th, 2018|Spine|
Read More

Surgeons call for ban on pedicle screw reuse and demand two-step asepsis process

14th September 2018 Contaminated pedicle screws cost hundreds of thousands of US dollars a year, and through an increase in surgical site infections result in additional and avoidable patient morbidity. Anand Agarwal (University of Toledo, Toledo, USA) and colleagues are calling for a change in the standard of care revolving around implant handling and delivery,

By |2018-09-24T14:19:40+00:00September 24th, 2018|Regulatory|
Read More

Biedermann Motech to launch iMAS 360™ procedure at NASS

Miami, FL - September 24, 2018 / Business Wire / – Biedermann Motech will launch the iMAS 360™ procedure at NASS 2018 in Los Angeles, September 26-28, 2018. Biedermann Motech, the developer of the world’s first polyaxial pedicle screw (MOSS System) and pioneer in the spinal market for more than 30 years, announced today the

By |2018-09-24T13:57:51+00:00September 24th, 2018|Spine, Top Stories|
Read More

Synergy Biomedical Announces Launch of BIOSPHERE MIS PUTTY

September 21, 2018 COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Synergy Biomedical, LLC, a developer of innovative biomaterial products, announced today that it has received FDA 510(k) clearance and is proceeding with a full commercial launch of BIOSPHERE® MIS PUTTY. BIOSPHERE® MIS PUTTY utilizes a pre-loaded bone graft cannula and trigger-based delivery system specifically designed for the unique challenges of minimally invasive

By |2018-09-21T17:56:15+00:00September 21st, 2018|Biologics|
Read More

Medtronic to Acquire Mazor Robotics

DUBLIN and CAESAREA, Israel - September 20, 2018 - Medtronic plc (NYSE:MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of robotic guidance systems, today announced the companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding ordinary shares of Mazor for $58.50

By |2018-09-21T16:08:08+00:00September 21st, 2018|Financial, Robotics, Top Stories|
Read More

Stryker’s Spine Division To Showcase Tritanium® In-Growth Technology in Augmented Reality Experience at NASS 2018

September 20, 2018 ALLENDALE, N.J.--(BUSINESS WIRE)--Stryker’s Spine division will feature its family of 3D-printed Tritanium interbody fusion cages and highlight its Tritanium In-Growth Technology1 in an augmented reality experience at the North American Spine Society Annual Meeting, Sept. 26–29, 2018, in Los Angeles (booth No. 1401). The augmented reality “tour” combines objects in the real world with

By |2018-09-21T15:28:09+00:00September 21st, 2018|Spine|
Read More

b-ONE Ortho Receives U.S. FDA 510(k) Clearance for Total Hip System

September 21, 2018 CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--b-ONE Ortho Corp., an emerging orthopedic technology company dedicated to the development of innovative healthcare solutions, today announced it has received 510(k) clearance for its first device, the b-ONETM Total Hip System, from the U.S. Food and Drug Administration (FDA). The b-ONETM Total Hip System is a cementless total hip system

By |2018-09-21T15:04:41+00:00September 21st, 2018|Recon, Regulatory, Top Stories|
Read More
Odysseus Medical Solutions 2018
RssEmail